Back to Details

clinical-trial-schema-designer

Compare original and translation side by side

🇺🇸

Original

English
🇨🇳

Translation

Chinese

Clinical Trial Schema Designer

临床试验架构设计工具

Purpose and Intent

用途与目标

The 
clinical-trial-schema-designer
bridges the gap between clinical research and data engineering. It helps automate the creation of standardized data structures (CDISC) based on clinical protocols, reducing the manual effort required for data ingestion and submission preparation.
clinical-trial-schema-designer
填补了临床研究与数据工程之间的空白。它可帮助基于临床试验方案自动创建标准化数据结构（CDISC），减少数据摄入和提交材料准备所需的人工工作量。

When to Use

适用场景

  • Study Setup: Use during the "Start-up" phase of a clinical trial to design the Electronic Data Capture (EDC) schemas.
  • Data Integration: When merging data from multiple sources into a single study standard.
  • Submission Prep: To ensure the data structure matches FDA/PMDA requirements for SDTM/ADaM.
  • 研究启动阶段：在临床试验的“启动”阶段使用，以设计电子数据采集（EDC）架构。
  • 数据集成：将多来源数据合并为统一的研究标准时使用。
  • 提交材料准备：确保数据结构符合FDA/PMDA对SDTM/ADaM的要求。

When NOT to Use

不适用场景

  • Unvalidated Systems: Clinical data must be handled in GxP-validated environments. This tool generates the design, but the implementation must follow strict validation protocols.
  • Medical Decision Making: This is a data structuring tool, not a clinical diagnostic or treatment tool.
  • 未验证系统：临床数据必须在符合GxP验证的环境中处理。本工具仅生成设计方案，具体实施必须遵循严格的验证流程。
  • 医疗决策：这是一款数据结构化工具，而非临床诊断或治疗工具。

Error Conditions and Edge Cases

错误情况与边缘案例

  • Ambiguous Protocols: If the input text is vague about how a variable is measured, the generated schema may be incomplete.
  • Non-Standard Studies: Phase 1 or highly experimental studies may use variables that don't fit existing CDISC domains perfectly.
  • 模糊方案：如果输入文本对变量的测量方式描述模糊，生成的架构可能不完整。
  • 非标准研究：I期或高度实验性研究可能使用不完全符合现有CDISC领域的变量。

Security and Data-Handling Considerations

安全与数据处理注意事项

  • IP Protection: Clinical protocols are intellectual property. Ensure the environment running this skill is secure.
  • No Patient Data: This tool works on protocols (the plan), not the actual results (the data).
  • 知识产权保护：临床试验方案属于知识产权。确保运行本工具的环境安全可靠。
  • 不涉及患者数据：本工具处理的是方案（研究计划），而非实际研究结果（数据）。